炎症性肠病患者脑-肠交互作用的双向性
该研究对405例克罗恩病或溃疡性结肠炎成人患者进行为期2年的纵向前瞻性研究,发现基线IBD活动与日后焦虑评分异常风险增加近6倍相关,而基线焦虑评分异常与日后需糖皮质激素处方或IBD活动复发及治疗升级相关,提示IBD活动与心理障碍存在双向影响。
要点
- 基线CD或UC疾病活动与日后焦虑评分异常风险增加近6倍相关(HR 5.77)。
- 基线静止期IBD患者中,基线焦虑评分异常与日后需糖皮质激素处方或IBD活动复发相关(HR 2.08)。
- 基线焦虑评分异常还与日后治疗升级相关(HR 1.82)。
核心结论
- 在为期2年的CD或UC患者研究中,发现IBD活动与心理障碍存在双向影响的证据。
- IBD患者应监测心理健康状况。
研究设计与样本
- 为期2年的纵向前瞻性研究,纳入405例诊断为克罗恩病或溃疡性结肠炎的成人患者,数据收集自2012年11月至2017年6月。
- 基线记录人口学特征、IBD亚型、治疗、症状、躯体化及粪便钙卫蛋白水平。
- 基线及随访期(2年或以上)后采用Harvey-Bradshaw指数评估CD活动、采用简易临床结肠炎活动指数评估UC活动(评分≥5分定义为疾病活动)。
- 基线及随访期后采用医院焦虑抑郁量表(HADS)收集焦虑和抑郁数据。
- 通过病历回顾评估疾病活动的客观标志物,包括糖皮质激素处方或疾病活动复发、治疗升级、因IBD活动住院及随访期间肠切除。
主要发现
- 基线CD或UC疾病活动与日后焦虑评分异常风险增加近6倍相关(HR 5.77;95% CI 1.89-17.7)。
- 基线静止期IBD患者中,基线焦虑评分异常与日后需糖皮质激素处方或IBD活动复发相关(HR 2.08;95% CI 1.31-3.30)。
- 基线焦虑评分异常与日后治疗升级相关(HR 1.82;95% CI 1.19-2.80)。
- 当采用正常IBD活动指数评分及粪便钙卫蛋白<250 μg/g定义基线静止期疾病时,上述关联持续存在。
关键数值与推荐
- 脑-肠方向定义为基线静止期IBD且HADS评分异常的患者日后出现新的IBD活动。
- 肠-脑方向定义为基线活动期IBD且HADS评分正常的患者日后出现HADS评分异常。
- CD疾病活动采用Harvey-Bradshaw指数评估,UC采用简易临床结肠炎活动指数评估,评分≥5分用于定义疾病活动。
- 粪便钙卫蛋白<250 μg/g用于定义基线静止期疾病。
临床怎么用
- 作者认为IBD患者应监测心理健康状况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Inflammatory bowel diseases (IBD) are associated with mood disorders, such as anxiety or depression, but it is not clear whether one contributes to development of the other, or if the interaction is bi-directional (anxiety or depression contributes to the progression of IBD, and IBD affects psychological health). We performed a 2-year longitudinal prospective study of patients in secondary to care investigate the bi-directionality of IBD and mood disorders. METHODS: We collected data from 405 adult patients with a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) from November 2012 through June 2017. Demographic features, subtypes of IBD, treatments, symptoms, somatization, and fecal level of calprotectin were recorded at baseline. IBD activity was determined at baseline and after the follow-up period (2 years or more) using the Harvey-Bradshaw Index for CD and the Simple Clinical Colitis Activity Index for UC (scores ≥5 used to define disease activity). Anxiety and depression data were collected using the Hospital Anxiety and Depression Scale (HADS), at baseline and after the follow-up period. Objective markers of disease activity, including glucocorticosteroid prescription or flare of disease activity, escalation of therapy, hospitalization secondary to IBD activity, and intestinal resection during follow-up were assessed via case note review. A brain-gut direction of disease activity was defined as development of new IBD activity in patients with quiescent IBD and abnormal HADS scores at baseline. A gut-brain direction of disease activity was defined by subsequent development of abnormal HADS scores in patients with active IBD and normal HADS scores at baseline. We performed multivariate Cox regression controlling for patient characteristics and follow-up duration. RESULTS: Baseline CD or UC disease activity were associated with an almost 6-fold increase in risk for a later abnormal anxiety score (hazard ratio [HR], 5.77; 95% CI, 1.89-17.7). In patients with quiescent IBD at baseline, baseline abnormal anxiety scores were associated with later need for glucocorticosteroid prescription or flare of IBD activity (HR, 2.08; 95% CI, 1.31-3.30) and escalation of therapy (HR, 1.82; 95% CI, 1.19-2.80). These associations persisted when normal IBD activity index scores and fecal level of calprotectin <250 μg/g were used to define quiescent disease at baseline. CONCLUSIONS: In a 2-year study of patients with CD or UC, we found evidence for bi-directional effects of IBD activity and psychological disorders. Patients with IBD should be monitored for psychological well-being.
引用
- Gracie DJ, Guthrie EA, Hamlin PJ, et al. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology. 2018. PMID: 29366841. doi:10.1053/j.gastro.2018.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。